New COPD inhaler shows promise in early trial

NCT ID NCT07633314

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new inhaled powder called TQC3927 for people with chronic obstructive pulmonary disease (COPD). The goal is to see if different doses can improve lung function and are safe over a short treatment period. About 90 adults aged 40 to 75 with COPD will take part. The study compares TQC3927 to an existing active drug to measure its effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chengdu Third People's Hospital

    Chengdu, Sichuan, 610031, China

  • Da Qing Long Nan Hospital

    Daqing, Heilongjiang, 163000, China

  • Jiangxi Provincal People's Hospital

    Nanchang, Jiangxi, 330000, China

  • Linfen Central Hospital

    Linfen, Shanxi, 041099, China

  • Northern Jiangsu People's Hospital

    Yangzhou, Jiangsu, 225000, China

  • Shanghai Pulmonary Hospital

    Shanghai, Shanghai Municipality, 200433, China

  • Siping Central People's Hospital

    Siping, Jilin, 136099, China

  • The 2th School of Medicine ,WMU/The 2th affiliated Hospital and Yuying Children's Hospital of WMU

    Wenzhou, Zhejiang, 325027, China

  • The First Affiliated Hospital of Shihezi University Shihezi

    Ürümqi, Xinjiang, 832008, China

  • The First People' Hospital Of YuLin

    Yulin, Guangxi, 537000, China

  • The Fourth Central Hospital of Tianjin

    Tianjin, Tianjin Municipality, 300140, China

  • The People's Hospital of Anyang City

    Anyang, Henan, 455099, China

  • Xiangtan County People's Hospital

    Xiangtan, Hunan, 411200, China

  • Yichang Central People's Hospital

    Yichang, Hubei, 443003, China

  • Yixing People'S Hospital

    Yixing, Jiangsu, 214200, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.